Literature DB >> 6353591

The influence of membrane skeleton on red cell deformability, membrane material properties, and shape.

N Mohandas, J A Chasis, S B Shohet.   

Abstract

A membrane skeleton consisting of a structural matrix of spectrin, actin, and band 4.1 linked to band 3 in the fluid bilayer through ankyrin appears to be responsible for many of the material properties of the red cell membrane. In response to externally applied forces, the membrane behaves as a solid, a semisolid, or a liquid, depending on the magnitude and duration of the applied forces. Under physiologic conditions, the normal skeleton permits the red cells to undergo marked reversible deformations as a viscoelastic material. Perturbations of this skeletal assembly, as a result of molecular defects in skeletal components, lead to various altered membrane material properties and altered behavior in the circulation. The altered material properties include increased elastic shear modulus, irreversible membrane flow, or even membrane yield, resulting in cell fragmentation. These alterations in turn lead to changes in cellular deformability either as a result of increased membrane rigidity or decreased surface-area-to-volume ratio, secondary to cell fragmentation. As cellular deformability is one of the major parameters that determines red cell life span, skeletal dysfunction leading to decreases in deformability can account for increased red cell destruction in many congenital and hereditary hemolytic anemias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353591

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  45 in total

Review 1.  Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence.

Authors:  Amy G Tsai; Axel Hofmann; Pedro Cabrales; Marcos Intaglietta
Journal:  Transfus Apher Sci       Date:  2010-06-19       Impact factor: 1.764

2.  Effect of magnesium ions on red cell membrane properties.

Authors:  G H Beaven; J Parmar; G B Nash; B M Bennett; W B Gratzer
Journal:  J Membr Biol       Date:  1990-12       Impact factor: 1.843

3.  Molecular basis for membrane rigidity of hereditary ovalocytosis. A novel mechanism involving the cytoplasmic domain of band 3.

Authors:  N Mohandas; R Winardi; D Knowles; A Leung; M Parra; E George; J Conboy; J Chasis
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

4.  Localization and structure of the ankyrin-binding site on beta2-spectrin.

Authors:  Lydia Davis; Khadar Abdi; Mischa Machius; Chad Brautigam; Diana R Tomchick; Vann Bennett; Peter Michaely
Journal:  J Biol Chem       Date:  2008-12-20       Impact factor: 5.157

5.  Time-dependent elastic extensional RBC deformation by micropipette aspiration: redistribution of the spectrin network?

Authors:  D Lerche; M M Kozlov; W Meier
Journal:  Eur Biophys J       Date:  1991       Impact factor: 1.733

6.  An elastic network model based on the structure of the red blood cell membrane skeleton.

Authors:  J C Hansen; R Skalak; S Chien; A Hoger
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

7.  Cytoplasmic pH and human erythrocyte shape.

Authors:  M M Gedde; D K Davis; W H Huestis
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

8.  Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking.

Authors:  L M Snyder; N L Fortier; J Trainor; J Jacobs; L Leb; B Lubin; D Chiu; S Shohet; N Mohandas
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Band 3 antagonists, p-azidobenzylphlorizin and DIDS, mediate erythrocyte shape and flexibility changes as characterized by digital image morphometry and microfiltration.

Authors:  D M Hoefner; M E Blank; B M Davis; D F Diedrich
Journal:  J Membr Biol       Date:  1994-07       Impact factor: 1.843

Review 10.  Red cell membrane: past, present, and future.

Authors:  Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.